
|
|
||||||
|
Medications
![]() ![]()
|
||||||
Daytrana and PregnancyTo date, there have been no studies conducted on Daytrana and pregnancy. However, in studies of the oral version of methylphenidate (the active ingredient in Daytrana), the medication caused birth defects when given to pregnant rats. Because of this, Daytrana has been given a pregnancy Category C classification by the FDA; however, a doctor may still prescribe Daytrana for a woman who is pregnant -- if the doctor believes that the benefits to the woman outweigh the potential risks to the unborn child.
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
|
||||||
|
||||||